N
Google TrendJONAS BROTHERS (500+) — Jonas Brothers postpone Birmingham concert over weather concerns
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:jonas brothers500+steven kwan500+kings vs warriors200+steffi graf200+boxing200+ben simmons500+lisa500+bill maher500+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "CD19 CAR T-Cell Therapy S" (30 stories)

Top Headline Story

Decade-long persistence of CD19 CAR T cells in B cell lymphomas
Lead StoryNaturegeneral
Aug 10

Decade-long persistence of CD19 CAR T cells in B cell lymphomas

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5OU194N01jMmpfNE9xM3dWc3l4Y252OHJlUjh2V3FUc1dvYnk1N2R5UXJmNGZ5NXdnSmZxenl0azJjUFNSZ210cVpoWUZUOWg2LWlHbnlqbmpKYUFhREVR?oc=5" target="_blank">Decade-long persistence of CD19 CAR T cells in B cell lymphomas</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
500+15m ago

jonas brothers

Jonas Brothers postpone Birmingham concert over weather concerns

Filter stories
500+15m ago

steven kwan

Guardians' Steven Kwan Could Shake Up Winter Outfield Market

Filter stories
200+15m ago

kings vs warriors

3 Storylines I'm Focused On in Warriors Preseason Game vs. Kings

Filter stories
200+15m ago

steffi graf

PICTURES: Steffi Graf & Daughter Jaz Feature In Andre Agassi’s ‘Photo Dump’ As Carlos Alcaraz & Karl-Anthony Towns Make Surprise Appearance

Filter stories

Search Results for "CD19 CAR T-Cell Therapy S"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
CAR-T cell therapy for autoimmune diseases: current clinical trial landscape and the next wave of development
Frontiersworld

CAR-T cell therapy for autoimmune diseases: current clinical trial landscape and the next wave of development

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxPNVMybzVIQUNISHh0ek8zZHRNZ0Nnd1E4bU1HUGRBdV9KQlFaa2VaM0JMcTNnelZxV1FTWnlqSjVOUF9iX3J0TmlCeS01bGkyTHk5bnRka0VITkgxblU3R0wyTFlCSmptendyYkZERlRnX0pDSFNwVXVBZHozT2lrYjdySUM5MHFPdnNfaXhWQW1rdw?oc=5" target="_blank">CAR-T cell therapy for autoimmune diseases: current clinical trial landscape and the next wave of development</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
CD19 CAR T-Cell Therapy for Treatment of Chronic Graft-versus-Host Disease
NEJMgeneral

CD19 CAR T-Cell Therapy for Treatment of Chronic Graft-versus-Host Disease

<a href="https://news.google.com/rss/articles/CBMiXkFVX3lxTFA5ZEVXbVpndFhCdkkyVU95VWxWbC1aTVdpT2NSaElibURZRm5PczZyMXNFbnFxLURfemQxUmJmQU1uUmJkcG1WYlhZUU9rLXNuQmk4cVM2ODFYUy1tQWc?oc=5" target="_blank">CD19 CAR T-Cell Therapy for Treatment of Chronic Graft-versus-Host Disease</a>  <font color="#6f6f6f">NEJM</font>

Read Full StoryMore like this
Statins May Augment Outcomes During CD19 CAR-T Therapy for R/R LBCL
Targeted Oncologygeneral

Statins May Augment Outcomes During CD19 CAR-T Therapy for R/R LBCL

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxPam1vWUNvV1dFbE5YN1ZKUWJoUHRZdHBoc09xVUJKSHp5UEdfajBsc1hpemVJUWJDSVhyNTNHZ1Z3YU9JSnhHZ3RWYVRXbm9LN0k4ZEx5Y2U1b0ZjUkFkNlpKa0lSVWROMXYxdjVnSDJFcC1NMmlqUE9CMVh4NW9aQ216ZmxLZS1pek1IOHNZbFcxbER1MVMxWG1yUFMzd21GRnc?oc=5" target="_blank">Statins May Augment Outcomes During CD19 CAR-T Therapy for R/R LBCL</a>  <font color="#6f6f6f">Targeted Oncology</font>

Read Full StoryMore like this
Flow cytometry‐based monitoring of chimeric antigen receptor (CAR) T cells: Reagent selection, assay design, and clinical utility
Wiley Online Librarypolitics

Flow cytometry‐based monitoring of chimeric antigen receptor (CAR) T cells: Reagent selection, assay design, and clinical utility

<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE00eWxZVkZZSXBDUFhHZ1A0ZE9hWG1VeFpJM1RNT2ZqbDgyVXNlaUF1WmJoUDdYb0pEREJ4b0VIUmJ3OXZzWkJNQ29yeTkyTFRiNC1vb2Q3R3UxUEdnUTJ3MC1qZEVOSnJQdFN3YVVn?oc=5" target="_blank">Flow cytometry‐based monitoring of chimeric antigen receptor (CAR) T cells: Reagent selection, assay design, and clinical utility</a>  <font color="#6f6f6f">Wiley Online Library</font>

Read Full StoryMore like this
CAR T cell therapy beyond cancer: current status, challenges and future prospects
Naturegeneral

CAR T cell therapy beyond cancer: current status, challenges and future prospects

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE43WVRRMkY3elBIcnp0TUJpV01HNEpabVNXcDY0WldTN3NEbk1faDNmWDdCdHVBNGtkOHlveVJwMnJ3b0dURUVvWV9rLVBKUzhsOVpmVU5LQ2tBNTA5ZVpN?oc=5" target="_blank">CAR T cell therapy beyond cancer: current status, challenges and future prospects</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Advancements and expanding applications of CAR-T cell therapy
Frontiersgeneral

Advancements and expanding applications of CAR-T cell therapy

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxQTlR4V0Z4QWFLVEJ6bThLVElqdDJTSVZFeXVOV2UzXzFwU21fVmljb2tXRjgzRU1OZHQtYlhrZzZfby15NmFkOExHQ2F1QWNOWXhFTWIyVEVKeGtJWmh2bU5KLUN6MVc4djZDV05lNXNxdUVWQmpoSGU1eGRvUVJuMEJnOGljMml5MzNDd1cxNXUwUQ?oc=5" target="_blank">Advancements and expanding applications of CAR-T cell therapy</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
CD19 CAR T-Cell Therapy for Autoimmune Hemolytic Anemia
The New England Journal of Medicineworld

CD19 CAR T-Cell Therapy for Autoimmune Hemolytic Anemia

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFA0S1JnNG9PUE1tV2RlNjJvM1poNkp3ckdpd3JWbG90VDFFYlJaTHU0LUg5NUp3YzZncFg3S0RUajcwc1hGWWdOUFVxaXZJc0ZOR3V6a1FrLUFibFRmNkJr?oc=5" target="_blank">CD19 CAR T-Cell Therapy for Autoimmune Hemolytic Anemia</a>  <font color="#6f6f6f">The New England Journal of Medicine</font>

Read Full StoryMore like this
A distinct CAR-T cell phenotype mediates therapeutic response at limited doses
Naturegeneral

A distinct CAR-T cell phenotype mediates therapeutic response at limited doses

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5WWmc4bHVqc1JUZFREUVNSNlNsSWdBamxQZ29nOGkwbXdHSFh4N0xYLW1iUUZ5SE9KdjRqUS1Sa0wxZW1wYnRId0lIcXFoT180dWZxMFB3Mk9qcUR5YnNN?oc=5" target="_blank">A distinct CAR-T cell phenotype mediates therapeutic response at limited doses</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Anti-CD19 CAR T-cell therapy for autoimmune diseases: from exploratory clinical trials to quantitative pharmacodynamic modeling development
Frontiersworld

Anti-CD19 CAR T-cell therapy for autoimmune diseases: from exploratory clinical trials to quantitative pharmacodynamic modeling development

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxPdC1RVVdBeVRhRGdZMXVRbjFaOG1zdi1rM3F2VEpKUEFteWFLREozQUpqWExic0htTzQ5ejl2UU5pN1RlMGxGWGU2ajdrMGlUM05tb0ZLN1dCdmFRZzdiS1BfNlN4eFp2dl9qNXZnQlhza1pjbHVaLWNGM2VyY3VsbDRFY3VjNEplRVFaUlJibHRsQQ?oc=5" target="_blank">Anti-CD19 CAR T-cell therapy for autoimmune diseases: from exploratory clinical trials to quantitative pharmacodynamic modeling development</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
Immunometabolic determinants of long-term response in leukemia patients receiving CD19 CAR T cell therapy
Natureworld

Immunometabolic determinants of long-term response in leukemia patients receiving CD19 CAR T cell therapy

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1SRGM1VWM3YXROcjBvcHF4V2d4Q3ppNkNCcnk1VVNpd2Q1WW1PX3FiREhrc2I3djdBcVRBTE1fcEtLN09qbTRqYzF6aDJkbENyRlpERGlvTXpKM20tWVRZ?oc=5" target="_blank">Immunometabolic determinants of long-term response in leukemia patients receiving CD19 CAR T cell therapy</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Case Report: Frontline CD19 CAR-T-cell therapy combined with targeted regimens induces durable complete remission in newly diagnosed secondary CNS lymphoma: a report of two cases
Frontiersgeneral

Case Report: Frontline CD19 CAR-T-cell therapy combined with targeted regimens induces durable complete remission in newly diagnosed secondary CNS lymphoma: a report of two cases

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxNekJ5YjkyVnVwVlJ6QmtUNXNhOUtPdEJXdjI5Ymk2SUJVMGx3YWMzcFJ0aUd4OVYyeTVMd1QwLV8xOEpvSWpkX2RfQ0pfZW5Gb3oydER5Tnl5M1g3dHRhT2EyOEs0Y1hCRGY0WDBxcy1Qb21ubUkyRWlGbk9iS052YWJwUW8yQmpJMFBnV0pn?oc=5" target="_blank">Case Report: Frontline CD19 CAR-T-cell therapy combined with targeted regimens induces durable complete remission in newly diagnosed secondary CNS lymphoma: a report of two cases</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
ITK-targeted immune remodeling enhanced the efficacy of anti-CD19 CAR-T cell therapy | Cell Death Discovery
Natureworld

ITK-targeted immune remodeling enhanced the efficacy of anti-CD19 CAR-T cell therapy | Cell Death Discovery

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE41Q1VWM2U2LVUxVzg3N2xGWG1Wd09QcjNRRGlNbFpTQzdJeUlxWDZWcDF1RngwUnRvSnFrVEdiV185R3RFWlRjblpRZUFxMFdLNWhWNmY1NXRJR3E1dFdj?oc=5" target="_blank">ITK-targeted immune remodeling enhanced the efficacy of anti-CD19 CAR-T cell therapy | Cell Death Discovery</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
When too late is too late: timing of CAR T-cell therapy in SLE & lupus nephritis
Frontiersgeneral

When too late is too late: timing of CAR T-cell therapy in SLE & lupus nephritis

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxQbmRoaFpiNHo4aUJobDF6SnpZSWRmMVBGREwzd1A4Rng0QThyUmczYmtvMkxCZUcyVFkwZ2JPQ0F3Nlp5b3hWYWdtVkR2UDdPM045c3NXNHQ3bGZWSFhhSFlKN2d0RUNqMThSVjhPTVdGUWlObFhzbk5teDNZdlBhZmM0WnBrX04zc2hESWdkZnc0dw?oc=5" target="_blank">When too late is too late: timing of CAR T-cell therapy in SLE & lupus nephritis</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
Pharmacokinetics of CAR T cells in multiple myeloma – the good, the bad, and the ugly
Naturegeneral

Pharmacokinetics of CAR T cells in multiple myeloma – the good, the bad, and the ugly

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFB3dXhHeFB5OVl1TndBX3kydWM1VDhUOUQzNjc2NlV3bUhxWURqakYxelhmYS1nZGdpWldOZDFwNVhXRnhRaFhvUmIwT1FPaUVvZldlOWtsOWpDUThqX2Zv?oc=5" target="_blank">Pharmacokinetics of CAR T cells in multiple myeloma – the good, the bad, and the ugly</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trial
Natureworld

CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trial

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE02Vzl5MzFWbUpoWUFpMHNJZG90bGxIV0JUNnlMbTZqenNJaGZPdk5QdWk3dlpzWXE3MEZ3X0M4eDI4b25EQzYyZEt0U0xJYjNGa2ppNVByQXNndHdKSk9z?oc=5" target="_blank">CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trial</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Allogeneic CD19 CAR T cells armed with an anti-rejection CD70 CAR overcome antigen escape and evade alloimmune responses
Natureworld

Allogeneic CD19 CAR T cells armed with an anti-rejection CD70 CAR overcome antigen escape and evade alloimmune responses

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFB5eUY4V2lEQjlicGFER0t2ZW1icVpwd2EwdTFteWdlekdIQVJiTVBGbFRiX3laX2VmODRZYzkxVHktVF9fNzU3Wmo4RVY2Q081VjVKSnRhMDF3bmtRRkFF?oc=5" target="_blank">Allogeneic CD19 CAR T cells armed with an anti-rejection CD70 CAR overcome antigen escape and evade alloimmune responses</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Balancing the efficacy and safety of chimeric antigen receptor T-cell therapy by affinity combination
Naturegeneral

Balancing the efficacy and safety of chimeric antigen receptor T-cell therapy by affinity combination

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBqVFF6UFd4RjAyV3BCQVhxX0t3SWtMTlJMSDNiN0lWZ3NUYTJlY21lUnJLN296QUpnWENFQmtySnBKc01Uc1dDSmFkX2xBU0NSZGswOHpPV0tFQnFlX1Fn?oc=5" target="_blank">Balancing the efficacy and safety of chimeric antigen receptor T-cell therapy by affinity combination</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
The TCR in CAR T cell therapy: use it or lose it?
Naturegeneral

The TCR in CAR T cell therapy: use it or lose it?

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBKbzAxRzFMZmE1Sl9pQzJMMzRRQ0RMdFZJUFA5VTJmNnJZLXRMQlM2ZHdUZDZXVEdsaWQ1WWwtYVhscXZNU0pSb190RC1XWmFRTWdidG9zS0ZTNGJ1Z1JZ?oc=5" target="_blank">The TCR in CAR T cell therapy: use it or lose it?</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Influence of B cell-lineage targeted CAR-T cell therapy on humoral immunity and vaccine-induced antibody response
Natureworld

Influence of B cell-lineage targeted CAR-T cell therapy on humoral immunity and vaccine-induced antibody response

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1nY3BMSTBlVFFMZUpkUkplTGQzN0VjV2FkRzdWVkpCb0JhUzVEMjNsc1RGZkZscGYxODhaMndieTVxWVA4UWc1Qy1KQTdZTkh4d3llZzYtLW9kaUE2cGh3?oc=5" target="_blank">Influence of B cell-lineage targeted CAR-T cell therapy on humoral immunity and vaccine-induced antibody response</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
A targeting lentiviral vector for generation of CAR-T cells in vivo
Naturegeneral

A targeting lentiviral vector for generation of CAR-T cells in vivo

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBqbk5kV29wekIwdTBSdEozRktldUUyc21HQjM3MzBkeWxEYTVfS1lJOThjMUJHbDJqVlg3Z3Vybk1LQ0wyX2dOdVNxU1pkbzB5VUk5MENjQ0lEX3U2Z2FN?oc=5" target="_blank">A targeting lentiviral vector for generation of CAR-T cells in vivo</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Therapy-related acute myeloid leukemia with 24-month latency after CD19 CAR-T cell therapy in relapsed/refractory diffuse large B-cell lymphoma: a case report
Frontiersgeneral

Therapy-related acute myeloid leukemia with 24-month latency after CD19 CAR-T cell therapy in relapsed/refractory diffuse large B-cell lymphoma: a case report

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxNdVpWYjU3ZGRFZnQ1dHdHb00xWlg3c3Z2TlJjQk5zZ3RQM2dNYXh6UmwwRDRocFc2RnAxb2JmU0hOcWIyR3pNcGk4SE1VVzFuVE1tY2hCcTR6T2NKcEZxNzVja19FaXhWdjZUYllwVFplQmpDei1EcExVMFh4aUxvdlZNRkZKejMzMHNDWFVB?oc=5" target="_blank">Therapy-related acute myeloid leukemia with 24-month latency after CD19 CAR-T cell therapy in relapsed/refractory diffuse large B-cell lymphoma: a case report</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
Adapting CAR-T and CAR-Treg cancer therapies for autoimmunity: innovations and challenges
Frontiersworld

Adapting CAR-T and CAR-Treg cancer therapies for autoimmunity: innovations and challenges

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxQS3FLVXlkaUxUZWRGdkw5N0taakNrbjZSdm9mNkFRbDJ4QUpfNF9oTjFOV0IyUnBfX3hkVFdhc2wxQnpFUVYxQnAxU0NTVEpqRV91MFkwQVhqRFdJTnJmWGlLcTI4elRneVpYczZkUDJ4VDhaRkFkM3dRSHJJX3JZY2RRMWV1ZExTS3lxZG9XMmJUQQ?oc=5" target="_blank">Adapting CAR-T and CAR-Treg cancer therapies for autoimmunity: innovations and challenges</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
CAR-T cell patients have depleted antibody immunity. Vaccination can restore it for some
Fred Hutchinson Cancer Research Centerworld

CAR-T cell patients have depleted antibody immunity. Vaccination can restore it for some

<a href="https://news.google.com/rss/articles/CBMigAFBVV95cUxOd2VjQkNCS0U0OGdnblM4bENMQ09GczZsTXAyWm1heGotT040Tm4xeW5HaVBndlhjbXk0N054Y2VlaGVxZC1qeTNQaWlzeWdrZ1R1QTk4Tk1aeDJaN0UwNE5LUVQtR2RTNHh3aHpXclZoVTAzX1gwSXBNcWdkaTd0eA?oc=5" target="_blank">CAR-T cell patients have depleted antibody immunity. Vaccination can restore it for some</a>  <font color="#6f6f6f">Fred Hutchinson Cancer Research Center</font>

Read Full StoryMore like this
CAR-T cell therapy for pancreatic cancer: Translating emerging targets and dual-targeting strategies from solid tumors
Frontiersgeneral

CAR-T cell therapy for pancreatic cancer: Translating emerging targets and dual-targeting strategies from solid tumors

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxQYUVsMlN5OUhhV3VaOXFRTlllZ2xJeUM2Z09tZTdmY1d6Y2VGak1ickI0X1IzX1VTVGFXOGgtbFROM2Q4YTRHdDJYNUtva0hxanlBV2kxN0JzTmhYODhOWWtLQXU2SUt1SktuOWg5VDdraEZHdl9leXBNdnBqVWVMNzhWVVBETjFWcmRaRVJUdlZvdw?oc=5" target="_blank">CAR-T cell therapy for pancreatic cancer: Translating emerging targets and dual-targeting strategies from solid tumors</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
CAR T cell therapy for fighting IPF: perspectives on a living drug
Frontiersgeneral

CAR T cell therapy for fighting IPF: perspectives on a living drug

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxNNlNmSU5GaTR2SllRUnFzQml6VXF4Y08wMEVVXzVwZWZCR0I0NWJId3JVVnNKTVhPZ0I1Qm1hOHpXZGJYeEp6SU1YNklnXzUta0R4QXB1aVFZOFZVMVJORW1SM09TTG12VHVsS3VqS3M1UzVJNU1xNEFzcTZnem41cVNCYmhxYTZGbTRYaGV0VjRxZw?oc=5" target="_blank">CAR T cell therapy for fighting IPF: perspectives on a living drug</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
BCMA/CD19 CAR T Shows Encouraging Results in R/R Multiple Myeloma
CancerNetworkgeneral

BCMA/CD19 CAR T Shows Encouraging Results in R/R Multiple Myeloma

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxNT1ByYmRXam0zeFhCXzN2SUdrdkpZbndSUkZBS1NhamlUOWxsZ09yc2pySTgzRkhkdWZBUi1RLVl3OUx4NmRTQURDZklUV0dZM1BCMGJ5ZF9oOXpWSkFuVTJSU0V3Y3ItRWZUSDdxR0ZXWHBXWEFXX3BHNThnd21kdzB3UVgxVEZ4Y1c2SlJqLThRYThjdHNhUUs0UE5YTkVtRkE?oc=5" target="_blank">BCMA/CD19 CAR T Shows Encouraging Results in R/R Multiple Myeloma</a>  <font color="#6f6f6f">CancerNetwork</font>

Read Full StoryMore like this
Precision immunotherapy with CAR-T cells in pediatric B-cell acute lymphoblastic leukemia: advances and unanswered challenges
Frontiersworld

Precision immunotherapy with CAR-T cells in pediatric B-cell acute lymphoblastic leukemia: advances and unanswered challenges

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxOblhtS2ZFTFJPbTE4V3NTaDhSUE1WRmloRERVU0xlQVduX2oxbVY5R2NVR1RNNmZLUU9HQklzbUhBLV9admhaZmFlYWFnUXI3aWx3WVFBNFZNampQT1BVOHc0M18wY1p5LXBoYmZkR2l3Z2pfV3hfNEpUZE95NDl1TUkwMWNWQjZpbDFHdk9B?oc=5" target="_blank">Precision immunotherapy with CAR-T cells in pediatric B-cell acute lymphoblastic leukemia: advances and unanswered challenges</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
Successful fresh formulation CD19 CAR-T cell therapy for GAD65 antibody-mediated cerebellar ataxia. A Case Report
Frontiersgeneral

Successful fresh formulation CD19 CAR-T cell therapy for GAD65 antibody-mediated cerebellar ataxia. A Case Report

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxQT0R6LWVYNHh1V0FKVW9Qel9McFhlSUtVMGtXc2g2VjhzZF9jVzVSZDhLcXg5dHFYeVBFcDFQWHhucUdVOTFzUVR2Y2VOWnR3d3pHdzZpTkZ5SkxoNlNsZFNCZV9BaGlZYnBSc1IxNlhraHV5N2RNS2pmNDhhc2Y5aFBvRUVvaFRJX1c4ckMwSjJoQQ?oc=5" target="_blank">Successful fresh formulation CD19 CAR-T cell therapy for GAD65 antibody-mediated cerebellar ataxia. A Case Report</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
Scarless circular mRNA-based CAR-T cell therapy elicits superior antitumor efficacy
Naturegeneral

Scarless circular mRNA-based CAR-T cell therapy elicits superior antitumor efficacy

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5fM3FFbDU5MldFT1BKMXZFdHY5dVBKZTJCMTdmU3YwQ3l0VGt6WGNHZjdUY2M0WmFFNGJ6b3lQNnpodk5FSmxjNGpDcjR2WGdWdjlQZ1M0MFBuVkZyV0pF?oc=5" target="_blank">Scarless circular mRNA-based CAR-T cell therapy elicits superior antitumor efficacy</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
"CD19 CAR T-Cell Therapy S" — Live Google News Trends & Headlines